NO20001894D0 - Use of TNF antagonists as drugs for the treatment of septic diseases - Google Patents

Use of TNF antagonists as drugs for the treatment of septic diseases

Info

Publication number
NO20001894D0
NO20001894D0 NO20001894A NO20001894A NO20001894D0 NO 20001894 D0 NO20001894 D0 NO 20001894D0 NO 20001894 A NO20001894 A NO 20001894A NO 20001894 A NO20001894 A NO 20001894A NO 20001894 D0 NO20001894 D0 NO 20001894D0
Authority
NO
Norway
Prior art keywords
drugs
treatment
tnf antagonists
septic diseases
septic
Prior art date
Application number
NO20001894A
Other languages
Norwegian (no)
Other versions
NO20001894L (en
Inventor
Hartmut Kupper
Martin Kaul
Juergen Eiselstein
Lothar Daum
Joachim Kempeni
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of NO20001894D0 publication Critical patent/NO20001894D0/en
Publication of NO20001894L publication Critical patent/NO20001894L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6869—Interleukin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
NO20001894A 1997-10-23 2000-04-12 Use of TNF antagonists as drugs for the treatment of septic diseases NO20001894L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19746868A DE19746868A1 (en) 1997-10-23 1997-10-23 Use of tumour necrosis factor antagonists
PCT/EP1998/006545 WO1999021582A2 (en) 1997-10-23 1998-10-15 Application of tnf antagonists as medicaments for treating septic diseases

Publications (2)

Publication Number Publication Date
NO20001894D0 true NO20001894D0 (en) 2000-04-12
NO20001894L NO20001894L (en) 2000-04-12

Family

ID=7846420

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20001894A NO20001894L (en) 1997-10-23 2000-04-12 Use of TNF antagonists as drugs for the treatment of septic diseases

Country Status (13)

Country Link
EP (1) EP1024831A2 (en)
JP (1) JP2001521009A (en)
KR (1) KR20010024549A (en)
CN (1) CN1163272C (en)
AU (1) AU756167B2 (en)
BR (1) BR9813114A (en)
CA (1) CA2306790A1 (en)
DE (1) DE19746868A1 (en)
HU (1) HUP0100105A3 (en)
IL (1) IL135083A0 (en)
NO (1) NO20001894L (en)
WO (1) WO1999021582A2 (en)
ZA (1) ZA989615B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2181297C2 (en) 2000-06-20 2002-04-20 Эпштейн Олег Ильич Method of treatment of pathological syndrome and medicinal agent
UA76639C2 (en) 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Homeopathic medication and method for treating erectile dysfunctions
UA76640C2 (en) * 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Method for correcting pathological immune responses and homeopathic medicinal agent
RU2309732C1 (en) 2006-03-13 2007-11-10 Олег Ильич Эпштейн Pressed solid oral formulation of medicinal preparation and method for preparing solid oral formulation of medicinal preparation
CA2804964C (en) 2010-07-15 2016-06-28 Oleg Iliich Epshtein Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract
US9308275B2 (en) 2010-07-15 2016-04-12 Oleg Iliich Epshtein Method of increasing the effect of an activated-potentiated form of an antibody
EP2415461B1 (en) * 2010-07-24 2012-10-31 Roche Diagnostics GmbH Stabilization of interleukin 6 in serum based solutions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2638652B2 (en) * 1988-07-18 1997-08-06 カイロン・コーポレーション Monoclonal antibody reacting with cachectin
GB9109645D0 (en) * 1991-05-03 1991-06-26 Celltech Ltd Recombinant antibodies
NZ278607A (en) * 1994-02-07 1999-05-28 Knoll Ag Use of tnf antagonists for treating disorders involving elevated serum levels of il-6 wherein the serum levels are 500pg/ml or above

Also Published As

Publication number Publication date
ZA989615B (en) 2000-04-20
AU1228499A (en) 1999-05-17
CN1163272C (en) 2004-08-25
WO1999021582A2 (en) 1999-05-06
AU756167B2 (en) 2003-01-09
WO1999021582A3 (en) 1999-07-15
CA2306790A1 (en) 1999-05-06
NO20001894L (en) 2000-04-12
IL135083A0 (en) 2001-05-20
BR9813114A (en) 2000-08-15
HUP0100105A3 (en) 2003-08-28
KR20010024549A (en) 2001-03-26
DE19746868A1 (en) 1999-04-29
JP2001521009A (en) 2001-11-06
EP1024831A2 (en) 2000-08-09
CN1277556A (en) 2000-12-20
HUP0100105A2 (en) 2001-05-28

Similar Documents

Publication Publication Date Title
IS5113A (en) Use of CB1 antagonists for the treatment of craving disorders
NO20006630D0 (en) Pharmaceutical composition for the treatment of diabetes
NO995221D0 (en) Sulfonamides for the treatment of endothelin-mediated diseases
NO20014379L (en) Use of Xenon for the Treatment of Neurointoxics
ATE447947T1 (en) PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF INSULINRESIENCE
DK0730864T3 (en) Medication for the treatment of inflammatory heart disease
DE69807466T2 (en) TRIPTOLID DERIVATIVES USEFUL FOR THE TREATMENT OF AUTOIMMUNE DISEASES
DE69838785D1 (en) PHARMACEUTICAL AGENTS FOR THE TREATMENT OF CEREBRAL AMYLOIDOSIS
NO20012106D0 (en) Drug for the treatment of bone pathobolism
NO20001894L (en) Use of TNF antagonists as drugs for the treatment of septic diseases
DE69822297D1 (en) TRIPTOLID DERIVATIVES SUITABLE FOR THE TREATMENT OF AUTOIMMUNE DISEASES
NO20020784L (en) Medication for the treatment of fractures
NO991734D0 (en) Pyrazolinones for the treatment of potency disorders
NO991164D0 (en) Pharmaceutical surface preparation for the treatment of viral diseases
NO20012612L (en) Isonipecotamides for the treatment of integrin-mediated diseases
NO20003799L (en) Incorporation of cholesterol-lowering agents into confectionary dosage forms
NO982562D0 (en) Composition for the treatment of pain
NO20002481D0 (en) Combination therapy for the treatment of AIDS
DE60043648D1 (en) MEDICAMENTS FOR THE TREATMENT OF PERIODONTAL DISEASES
DK0900078T3 (en) Use of benzonaphthalene derivatives for the manufacture of drugs for the treatment of diseases of the nervous system
NO995940D0 (en) Use of leptin antagonists for the treatment of diabetes
ID24439A (en) USE OF TIAZOLIDINDION FOR HYPERGLICEMIA TREATMENT
IT1296706B1 (en) POLYMER FOR THE TREATMENT OF PERIODONTAL DISEASES
IT1293464B1 (en) ELECTROMEDICAL DEVICE FOR THE TREATMENT OF ACUTE INFLAMMATORY DISEASES
ITVR980074A0 (en) PHARMACEUTICAL COMPOUND FOR THE TREATMENT OF SKIN DISEASES.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application